Burnett A - Search Results

1

Changing p53 mutations with the evolution of chronic myeloid leukaemia from the chronic phase to blast crisis.

Guinn BA, Smith M, Padua RA, Burnett A, Mills K. Guinn BA, et al. Among authors: burnett a. Leuk Res. 1995 Aug;19(8):519-25. doi: 10.1016/0145-2126(95)00024-i. Leuk Res. 1995. PMID: 7658697

2

In vitro drug resistance in acute myeloid and chronic B-lymphocytic leukaemic blasts and in normal blood and marrow populations.

Baines P, Limaye M, Hoy T, Padua RA, Whittaker J, al-Sabah A, Burnett A. Baines P, et al. Among authors: burnett a. Leuk Res. 1994 Sep;18(9):683-91. doi: 10.1016/0145-2126(94)90068-x. Leuk Res. 1994. PMID: 7934144

3

p53 mutations indicate a changing clonal evolution in a portion of chronic myelocytic leukemia patients.

Guinn BA, Padua RA, Burnett A, Mills K. Guinn BA, et al. Among authors: burnett a. Blood. 1994 Nov 15;84(10):3591. Blood. 1994. PMID: 7949113 Free article. No abstract available.

4

Molecular evidence for a common leukaemic progenitor in acute mixed lymphoid and myeloid leukaemia.

Lim SH, Culligan D, Couzens S, Fisher J, John S, Pollard P, Burnett A, Whittaker J. Lim SH, et al. Among authors: burnett a. Br J Haematol. 1996 Jan;92(1):131-3. doi: 10.1046/j.1365-2141.1996.281821.x. Br J Haematol. 1996. PMID: 8562383

5

Allelic loss of the FMS gene in acute myeloid leukaemia.

McGlynn H, Kapelko K, Baker A, Burnett A, Padua RA. McGlynn H, et al. Among authors: burnett a. Leuk Res. 1997 Oct;21(10):919-23. doi: 10.1016/s0145-2126(97)00024-6. Leuk Res. 1997. PMID: 9403002

6

Increased circulating normal and BCR-ABL+Ve progenitor numbers in Philadelphia chromosome-positive acute myeloid leukaemia.

Baines P, Austin S, Fisher J, Owen-Jones E, Lee-Jones L, Throp D, Mckinley M, Hoy T, Mills K, Thompson P, Burnett A. Baines P, et al. Among authors: burnett a. Leuk Res. 2002 Nov;26(11):997-1005. doi: 10.1016/s0145-2126(02)00049-8. Leuk Res. 2002. PMID: 12363468

7

Microarray analysis of tumour antigen expression in presentation acute myeloid leukaemia.

Guinn BA, Gilkes AF, Woodward E, Westwood NB, Mufti GJ, Linch D, Burnett AK, Mills KI. Guinn BA, et al. Biochem Biophys Res Commun. 2005 Aug 5;333(3):703-13. doi: 10.1016/j.bbrc.2005.05.161. Biochem Biophys Res Commun. 2005. PMID: 15963951

8

Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia.

Gale RE, Hills R, Pizzey AR, Kottaridis PD, Swirsky D, Gilkes AF, Nugent E, Mills KI, Wheatley K, Solomon E, Burnett AK, Linch DC, Grimwade D; NCRI Adult Leukaemia Working Party. Gale RE, et al. Blood. 2005 Dec 1;106(12):3768-76. doi: 10.1182/blood-2005-04-1746. Epub 2005 Aug 16. Blood. 2005. PMID: 16105978 Free article.

9

The tumour antigens RAGE-1 and MGEA6 are expressed more frequently in the less lineage restricted subgroups of presentation acute myeloid leukaemia.

Guinn BA, Gilkes AF, Mufti GJ, Burnett AK, Mills KI. Guinn BA, et al. Br J Haematol. 2006 Jul;134(2):238-9. doi: 10.1111/j.1365-2141.2006.06135.x. Br J Haematol. 2006. PMID: 16846483 Free article. No abstract available.

10

The effects of lestaurtinib (CEP701) and PKC412 on primary AML blasts: the induction of cytotoxicity varies with dependence on FLT3 signaling in both FLT3-mutated and wild-type cases.

Knapper S, Mills KI, Gilkes AF, Austin SJ, Walsh V, Burnett AK. Knapper S, et al. Blood. 2006 Nov 15;108(10):3494-503. doi: 10.1182/blood-2006-04-015487. Epub 2006 Jul 25. Blood. 2006. PMID: 16868253 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,410 results

Search Page